Page last updated: 2024-09-04

tuftsin and Fibrosarcoma

tuftsin has been researched along with Fibrosarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Catane, R; Fridkin, M; Fuks, Z; Gottlieb, P; Penchas, S; Schlanger, S; Treves, AJ; Weiss, L1
Babcock, GF; Banks, RA; Kazazi, F; Nishioka, K1

Trials

1 trial(s) available for tuftsin and Fibrosarcoma

ArticleYear
Toxicology and antitumor activity of tuftsin.
    Annals of the New York Academy of Sciences, 1983, Volume: 419

    Topics: Adult; Aged; Aging; Animals; Clinical Trials as Topic; Cytotoxicity, Immunologic; Dogs; Female; Fibrosarcoma; Humans; Lethal Dose 50; Leukocyte Count; Leukocytosis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Middle Aged; Neoplasm Transplantation; Neoplasms; Spleen; T-Lymphocytes, Cytotoxic; Tuftsin

1983

Other Studies

1 other study(ies) available for tuftsin and Fibrosarcoma

ArticleYear
Effect of tuftsin on in vivo development of 3-methylcholanthrene-induced primary fibrosarcoma and Lewis lung carcinoma in mice.
    Journal of the National Cancer Institute, 1985, Volume: 74, Issue:5

    Topics: Animals; Carcinoma; Cell Line; Fibrosarcoma; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred C57BL; Tuftsin

1985